The compound at the center of the dispute is semaglutide, a GLP-1 receptor agonist that helps regulate blood sugar and appetite
In partnership with Novo Nordisk, GoodRx is also offering a limited-time introductory price of $199 per month for the lowest doses of Ozempic and Wegovy to first-time, self-paying customers
doi: 10.1038/sj.bjp.0704315, 74
Beyond their original design for diabetes and the notable side effect of losing significant amounts of weight, clinical trials have shown that GLP-1s reduce the risk of heart attacks, strokes, kidney disease progression, heart failure, and even COVID-19 mortality
Speeds Up Wound HealingandMuscle Regeneration
The answer is yes for most TRICARE plans, but there are important details to understand, especially after the policy changes that took effect in August 2025